Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
ACS Appl Mater Interfaces ; 13(36): 42396-42410, 2021 Sep 15.
Article in English | MEDLINE | ID: mdl-34472332

ABSTRACT

Chronic wound healing, impeded by bacterial infections and drug resistance, poses a threat to global human health. Antibacterial phototherapy is an effective way to fight microbial infection without causing drug resistance. Covalent organic frameworks (COFs) are a class of highly crystalline functional porous carbon-based materials composed of light atoms (e.g., carbon, nitrogen, oxygen, and borane), showing potential applications in the biomedical field. Herein, we constructed porphyrin-based COF nanosheets (TP-Por CON) for synergizing photodynamic and photothermal therapy under red light irradiation (e.g., 635 nm). Moreover, a nitric oxide (NO) donor molecule, BNN6, was encapsulated into the pore volume of the crystalline porous framework structure to moderately release NO triggered by red light irradiation for realizing gaseous therapy. Therefore, we successfully synthesized a novel TP-Por CON@BNN6-integrated heterojunction for thoroughly killing Gram-negative bacteria Escherichia coli and Gram-positive bacteria Staphylococcus aureus in vitro. Our research identified that TP-Por CON@BNN6 has favorable biocompatibility and biodegradability, low phototoxicity, anti-inflammatory properties, and excellent mice wound healing ability in vivo. This study indicates that the TP-Por CON@BNN6-integrated heterojunction with multifunctional properties provides a potential strategy for COF-based gaseous therapy and microorganism-infected chronic wound healing.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Metal-Organic Frameworks/therapeutic use , Nitric Oxide Donors/therapeutic use , Photosensitizing Agents/therapeutic use , Staphylococcal Skin Infections/drug therapy , Wound Healing/drug effects , Animals , Anti-Inflammatory Agents/radiation effects , Anti-Inflammatory Agents/toxicity , Cell Line , Escherichia coli/drug effects , Light , Metal-Organic Frameworks/radiation effects , Metal-Organic Frameworks/toxicity , Mice, Inbred BALB C , Nitric Oxide Donors/radiation effects , Nitric Oxide Donors/toxicity , Photosensitizing Agents/radiation effects , Photosensitizing Agents/toxicity , Porphyrins/radiation effects , Porphyrins/therapeutic use , Porphyrins/toxicity , Staphylococcus aureus/drug effects
2.
ACS Appl Mater Interfaces ; 13(37): 43855-43867, 2021 Sep 22.
Article in English | MEDLINE | ID: mdl-34494809

ABSTRACT

Black phosphorus (BP) nanosheet is easily oxidized by oxygen and water under ambient environment, thus, reliable BP passivation techniques for biomedical applications is urgently needed. A simple and applicable passivation strategy for biomedical applications was established by encapsulating BP nanosheet into zeolitic imidazole framework-8 (ZIF-8). The resulted BP nanosheet in ZIF-8 (BP@ZIF-8) shows not only satisfied chemical stability in both water and phosphate buffered saline (PBS), but also excellent biocompatibility. Notably, BP nanosheet endows the prepared BP@ZIF-8 with prominent photothermal conversion efficiency (31.90%). Besides passivation BP, ZIF-8 provides the BP@ZIF-8 with high drug loading amount (1353.3 mg g-1). Moreover, the loaded drug can be controlled release by pH stimuli. Both in vitro and in vivo researches verified the resulted BP@ZIF-8 an ideal candidate for tumor multimodal treatments.


Subject(s)
Antineoplastic Agents/therapeutic use , Drug Carriers/chemistry , Metal-Organic Frameworks/chemistry , Nanostructures/chemistry , Neoplasms/drug therapy , Phosphorus/chemistry , Animals , Antineoplastic Agents/chemistry , Cell Line, Tumor , Combined Modality Therapy , Doxorubicin/chemistry , Doxorubicin/therapeutic use , Drug Carriers/radiation effects , Drug Carriers/toxicity , Drug Liberation , Drug Therapy , Female , Humans , Hydrogen-Ion Concentration , Infrared Rays , Metal-Organic Frameworks/radiation effects , Metal-Organic Frameworks/toxicity , Mice , Nanostructures/radiation effects , Nanostructures/toxicity , Phosphorus/radiation effects , Phosphorus/toxicity , Photothermal Therapy
3.
J Mater Chem B ; 8(37): 8671-8683, 2020 09 30.
Article in English | MEDLINE | ID: mdl-32856668

ABSTRACT

Multifunctional nanomedical platforms have broad prospects in imaging-guided combination therapy in cancer precision medicine. In this work, metal-organic framework (MOF)-derived novel porous Fe3O4@C nanocomposites were developed as an intelligent cancer nanomedical platform for combined cancer therapy with MRI-guided magnetic-triggered hyperthermia and chemotherapy functions. The magnetic behavior, porous character and good surface modification endowed this smart nanoplatform with favorable biocompatibility, high-efficiency MRI imaging, magnetic-triggered on-demand DOX release function, and synergistic therapy of magnetic hyperthermia and chemotherapy, which proposed an all-in-one platform for cancer therapy. Additionally, in vivo animal experiments verified the significant suppression of malignant tumor growth with negligible side effects, which were attributed to the consecutive 13 day synergistic therapy of magnetic hyperthermia and chemotherapy in one. To be specific, Fe3O4@C-PVP@DOX significantly decreases the volume (2.5 to 0.44 of tumor volume ratio) and weight (0.49 g to 0.10 g) of tumors after magnetic-triggered hyperthermia and chemotherapy treatments. Moreover, no big difference of body weight and associated damage was observed among all major organs. Therefore, owing to its high-efficiency combined therapy of magnetic-triggered hyperthermia and chemotherapy, this smart nanoplatform holds great potential application in the precise treatments of clinical cancer.


Subject(s)
Antineoplastic Agents/therapeutic use , Drug Carriers/therapeutic use , Magnetite Nanoparticles/therapeutic use , Metal-Organic Frameworks/therapeutic use , Nanocomposites/therapeutic use , Neoplasms/drug therapy , Animals , Antineoplastic Agents/chemistry , Cell Line, Tumor , Combined Modality Therapy/methods , Doxorubicin/chemistry , Doxorubicin/therapeutic use , Drug Carriers/chemistry , Drug Carriers/toxicity , Drug Liberation , Drug Therapy/methods , Humans , Hyperthermia, Induced/methods , Magnetic Phenomena , Magnetite Nanoparticles/chemistry , Magnetite Nanoparticles/toxicity , Male , Metal-Organic Frameworks/chemistry , Metal-Organic Frameworks/toxicity , Mice , Mice, Inbred BALB C , Mice, Nude , NIH 3T3 Cells , Nanocomposites/chemistry , Nanocomposites/toxicity , Porosity , Povidone/chemistry , Povidone/toxicity , Xenograft Model Antitumor Assays
4.
J Mater Chem B ; 7(31): 4763-4770, 2019 08 07.
Article in English | MEDLINE | ID: mdl-31389960

ABSTRACT

Nanomaterial-mediated phototherapy, including photodynamic therapy (PDT) and photothermal therapy (PTT), is an effective anticancer intervention that relies on light activation of photoactive nanomaterials localized in tumors. Recently, combinational PDT/PTT offered a practical pathway to relieve resistance of monotherapy, surmount undesirable side effects and provide a synergistic effect to enhance phototherapeutic efficiency. Herein, we report a facile strategy to integrate protoporphyrin IX (PpIX) into nanoscale metal-organic frameworks (NMOFs) and control their photoactive properties for combinational cancer PDT and PTT. With optimized PpIX conjugation, the as-fabricated nanoparticles (nPCU NPs) exhibit (1) improved dispersibility and particle stability, (2) simultaneous generation of reactive oxygen species and heat effectively through activation by a single-wavelength laser of 635 nm, and (3) maintenance of porosity for further application as drug delivery vehicles. Moreover, in vitro investigation of nPCU NPs demonstrates effective cellular uptake, successful endosomal escape and enhanced phototherapeutic efficacy under both normoxic and hypoxic conditions. Therefore, this study developed a novel type of phototherapeutic nanoplatform with optimal properties for applicable cancer phototherapy.


Subject(s)
Antineoplastic Agents/pharmacology , Drug Carriers/chemistry , Metal Nanoparticles/chemistry , Metal-Organic Frameworks/chemistry , Photosensitizing Agents/pharmacology , Protoporphyrins/pharmacology , Antineoplastic Agents/radiation effects , Cell Line, Tumor , Doxorubicin/pharmacology , Drug Carriers/toxicity , Humans , Hyperthermia, Induced/methods , Light , Metal Nanoparticles/toxicity , Metal-Organic Frameworks/toxicity , Photochemotherapy/methods , Photosensitizing Agents/radiation effects , Proof of Concept Study , Protoporphyrins/radiation effects , Tumor Hypoxia/drug effects
5.
J Mater Chem B ; 7(15): 2398-2420, 2019 04 21.
Article in English | MEDLINE | ID: mdl-32255118

ABSTRACT

Increasing attention has been given to the field of porous organic frameworks (POFs) due to their unique properties, outstanding performance, and broad applications. Given their extremely high surface area, ordered crystal structure, and ease of tailoring, POFs are promising candidates for gas adsorption and separation, catalysis, supercapacitors, chemosensors, and bio-related applications. Furthermore, their tunable pore size and high agent loading capacity make them promising candidates for drug delivery, whereas their ease of functionalization leads to target specificity and long blood circulation times, which are important properties in bioimaging. For biosensing applications, the pores and channels of POFs can accommodate target molecules and induce specific recognition. POFs can also be applied in phototherapy in combination with photosensitizers. Finally, POF-based artificial shells can encapsulate bioactive molecules and strengthen the resistance of cells to adverse environmental conditions. In this review, we will highlight the research progress of POF-based bio-related applications, including drug delivery, bioimaging, biosensing agents, as well as in phototherapy and artificial shells. Furthermore, the in vitro and in vivo toxicological studies of POFs are discussed as are the prospects and future research directions for POFs in bio-related applications.


Subject(s)
Biocompatible Materials/chemistry , Metal-Organic Frameworks/chemistry , Animals , Biocompatible Materials/pharmacology , Biocompatible Materials/therapeutic use , Biocompatible Materials/toxicity , Humans , Metal-Organic Frameworks/pharmacology , Metal-Organic Frameworks/therapeutic use , Metal-Organic Frameworks/toxicity , Porosity
SELECTION OF CITATIONS
SEARCH DETAIL